{"id":"W4387665269","doi":"10.1038/s41375-023-02064-y","title":"Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Merck Sharp and Dohme; Bristol-Myers Squibb Canada; Takeda Medical Research Foundation; Gilead Sciences; Roche; AstraZeneca; Miltenyi Biotec; Novartis; Deutsche Krebshilfe; Amgen; Pfizer; AbbVie; Staatssekretariat für Bildung, Forschung und Innovation; Merck","keywords":"Medicine; ABVD; Stage (stratigraphy); Internal medicine; Progression-free survival; Nuclear medicine; Hodgkin lymphoma; Hodgkin's lymphoma; Lymphoma; Randomized controlled trial; Overall survival; Oncology; Gastroenterology; Chemotherapy; Vincristine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004908155,0.0006343969,0.001381669,0.0002136456,0.0002382103,0.0006243159,0.0003719554,0.0008758336,0.001224642],"category_scores_gemma":[0.002117228,0.0003202781,0.001423454,0.0002845179,0.0006876912,0.0004859038,0.000329813,0.001421003,0.0002300358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006777722,"about_ca_system_score_gemma":0.0006148507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008366128,"about_ca_topic_score_gemma":0.00339477,"domain_scores_codex":[0.998185,0.001373446,0.00006863964,0.0001121365,0.0001190919,0.0001415997],"domain_scores_gemma":[0.998623,0.0005099764,0.0003193406,0.0001618753,0.00006800041,0.0003177969],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8992648,0.003370529,0.02284623,0.000486443,0.003572168,0.0001047365,0.000141948,0.001910393,0.005726411,0.0002500293,0.001999228,0.06032709],"study_design_scores_gemma":[0.5862732,0.2808676,0.1152808,0.0001915152,0.004599532,0.0002799829,0.00007863559,0.00155334,0.003481986,0.0007370955,0.006599023,0.00005732495],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918908,0.005461374,0.0002742501,0.0004298291,0.0001468518,0.0002472537,0.0005944843,0.0000161495,0.0009389769],"genre_scores_gemma":[0.9956284,0.001123649,0.0003110058,0.0005325106,0.0001626468,0.0002075131,0.00097432,0.000007880646,0.001052218],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004908155,"threshold_uncertainty_score":0.02595717,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03527321674574106,"score_gpt":0.2918585803965159,"score_spread":0.2565853636507748,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}